Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives

Gillespie, Roger J., Adams, David R., Bebbington, David, Benwell, Karen, Cliffe, Ian A., Dawson, Claire E., Dourish, Colin T., Fletcher, Allan, Gaur, Suneel, Giles, Paul R., Jordan, Allan M., Knight, Antony R., Knutsen, Lars J.S., Lawrence, Anthony, Lerpiniere, Joanne, Misra, Anil, Porter, Richard H.P., Pratt, Robert M., Shepherd, Robin, Upton, Rebecca, Ward, Simon ORCID: https://orcid.org/0000-0002-8745-8377, Weiss, Scott M. and Williamson, Douglas S. 2008. Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives. Biorganic and Medicinal Chemistry Letters 18 (9) , pp. 2916-2919. 10.1016/j.bmcl.2008.03.075

Full text not available from this repository.

Abstract

The (−)-(11R,2′S)-enantiomer of the antimalarial drug mefloquine has been found to be a reasonably potent and moderately selective adenosine A2A receptor antagonist. Further investigation of this compound has led to the discovery of a series of keto-aryl thieno[3,2-d]pyrimidine derivatives, which are potent and selective antagonists of the adenosine A2A receptor. These derivatives show selectivity against the A1 receptor. Furthermore, some of these compounds have been shown to have in vivo activity in a commonly used model, suggesting the potential for the treatment of Parkinson’s disease.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Uncontrolled Keywords:	Adenosine A2A receptor, Parkinson’s disease, Mefloquine
Publisher:	Elsevier
ISSN:	0960-894X
Date of Acceptance:	27 March 2008
Last Modified:	23 Oct 2022 12:59
URI:	https://orca.cardiff.ac.uk/id/eprint/109351

Citation Data

Cited 42 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item